1AD 4.00% 2.4¢ adalta limited

Ann: AD-214 pathway to IPF efficacy studies, page-58

  1. 438 Posts.
    lightbulb Created with Sketch. 6
    and importantly this data is only a handful of months after the data was likely expected anyway...
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.